davos life science
Davos Life Sciences Takes Tocotrienol Product Into Phase I Trials
Davos Life Science announced today preliminary results of a Phase I clinical trial of its Natural e3 delta-tocotrienol (Natural e3) in patients with resectable pancreatic cancer.



